A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma

Clinical trial NCT00136591 · TERMINATED

Trial details

NCT number: NCT00136591
Sponsor: Lymphoma Study Association
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2005-09-01
Primary completion: 2010-01-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.